Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Raman

Showing results (401-410 of 455) with videos related to

Pageof 46
Sort By:
European Urology|February 22, 2012
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgeryMichael Rink, Behfar Ehdaie, Eugene K Cha, et al.
Urologic Oncology|May 11, 2010
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomyJeffery C Wheat, Alon Z Weizer, J Stuart Wolf, et al.
The Journal of Urology|December 3, 2014
Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tractLaura-Maria Krabbe, Aditya Bagrodia, Ahmed Q Haddad, et al.
Urology|February 9, 2024
Gender-based Disparity Exists in the Surgical Experience of Female and Male Urology ResidentsKathryn A Marchetti, Charles A Ferreri, Emma C Bethel, et al.
Urology|December 3, 2014
Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinomaAditya Bagrodia, Laura-Maria Krabbe, Bishoy A Gayed, et al.
Urologic Oncology|August 1, 2015
Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional studyRomain Mathieu, Tobias Klatte, Vitaly Margulis, et al.
The Journal of Urology|September 28, 2016
Postoperative Nomogram for Relapse-Free Survival in Patients with High Grade Upper Tract Urothelial CarcinomaLaura-Maria Krabbe, Okyaz Eminaga, Shahrokh F Shariat, et al.
European Urology|January 31, 2012
Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classificationShahrokh F Shariat, Richard Zigeuner, Michael Rink, et al.
European Urology|January 7, 2014
Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinomaDaniel J Lee, Evanguelos Xylinas, Malte Rieken, et al.
Urologic Oncology|May 12, 2018
Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinomaNirmish Singla, Laura-Maria Krabbe, Ahmet M Aydin, et al.
Pageof 46

Showing results (401-410 of 455) with videos related to

Sort By:
Pageof 46
European Urology|February 22, 2012
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgeryMichael Rink, Behfar Ehdaie, Eugene K Cha, et al.
Urologic Oncology|May 11, 2010
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomyJeffery C Wheat, Alon Z Weizer, J Stuart Wolf, et al.
The Journal of Urology|December 3, 2014
Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tractLaura-Maria Krabbe, Aditya Bagrodia, Ahmed Q Haddad, et al.
Urology|February 9, 2024
Gender-based Disparity Exists in the Surgical Experience of Female and Male Urology ResidentsKathryn A Marchetti, Charles A Ferreri, Emma C Bethel, et al.
Urology|December 3, 2014
Evaluation of the prognostic significance of altered mammalian target of rapamycin pathway biomarkers in upper tract urothelial carcinomaAditya Bagrodia, Laura-Maria Krabbe, Bishoy A Gayed, et al.
Urologic Oncology|August 1, 2015
Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional studyRomain Mathieu, Tobias Klatte, Vitaly Margulis, et al.
The Journal of Urology|September 28, 2016
Postoperative Nomogram for Relapse-Free Survival in Patients with High Grade Upper Tract Urothelial CarcinomaLaura-Maria Krabbe, Okyaz Eminaga, Shahrokh F Shariat, et al.
European Urology|January 31, 2012
Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classificationShahrokh F Shariat, Richard Zigeuner, Michael Rink, et al.
European Urology|January 7, 2014
Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinomaDaniel J Lee, Evanguelos Xylinas, Malte Rieken, et al.
Urologic Oncology|May 12, 2018
Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinomaNirmish Singla, Laura-Maria Krabbe, Ahmet M Aydin, et al.
Pageof 46